Skip Navigation


Human Molecular Genetics Advance Access originally published online on October 20, 2004
Human Molecular Genetics 2004 13(24):3161-3170; doi:10.1093/hmg/ddh330
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
13/24/3161    most recent
ddh330v3
ddh330v2
ddh330v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lee, H.-Y.
Right arrow Articles by Ptácek, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, H.-Y.
Right arrow Articles by Ptácek, L. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol. 13, No. 24 © Oxford University Press 2004; all rights reserved

The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway

Hsien-Yang Lee1,2, Ying Xu1, Yong Huang1, Andrew H. Ahn1, Georg W.J. Auburger3, Massimo Pandolfo4, Hubert Kwiecinski5, David A. Grimes6, Anthony E. Lang7, Jorgen E. Nielsen8, Yuri Averyanov9, Serenella Servidei10, Andrzej Friedman5, Patrick Van Bogaert4, Marc J. Abramowicz4, Michiko K. Bruno1,11, Beatrice F. Sorensen1, Ling Tang2, Ying-Hui Fu1 and Louis J. Ptácek1,12,*

1Department of Neurology, UCSF, San Francisco, CA, USA, 2Department of Human Genetics, University of Utah, Salt Lake City, UT, USA, 3JW Goethe University Hospital, Frankfurt/M, Germany, 4Erasme Hospital, Brussels, Belgium, 5Department of Neurology, Medical Academy of Warsaw, Warsaw, Poland, 6University of Ottawa, Ottawa Hospital, Division of Neurology, D715, Ottawa, Canada, 7University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada, 8Institute of Medical Biochemistry and Genetics, The Panum Institute, University of Copenhagen, Copenhagen, Denmark, 9Clinic of Nervous Diseases, Moscow Medical Academy, Moscow, Russia, 10Institute of Neurology, Catholic University, Rome, Italy, 11National Institutes of Health/National Institute of Neurological Diseases and Stroke, Bethesda, MD, USA and 12Howard Hughes Medical Institute, San Francisco, USA

Received August 23, 2004; Accepted October 11, 2004

Paroxysmal non-kinesigenic dyskinesia (PNKD) is characterized by spontaneous hyperkinetic attacks that are precipitated by alcohol, coffee, stress and fatigue. We report mutations in the myofibrillogenesis regulator 1 (MR-1) gene causing PNKD in 50 individuals from eight families. The mutations cause changes (Ala to Val) in the N-terminal region of two MR-1 isoforms. The MR-1L isoform is specifically expressed in brain and is localized to the cell membrane while the MR-1S isoform is ubiquitously expressed and shows diffuse cytoplasmic and nuclear localization. Bioinformatic analysis reveals that the MR-1 gene is homologous to the hydroxyacylglutathione hydrolase (HAGH) gene. HAGH functions in a pathway to detoxify methylglyoxal, a compound present in coffee and alcoholic beverages and produced as a by-product of oxidative stress. Our results suggest a mechanism whereby alcohol, coffee and stress may act as precipitants of attacks in PNKD. Stress response pathways will be important areas for elucidation of episodic disease genetics where stress is a common precipitant of many common disorders like epilepsy, migraine and cardiac arrhythmias.

* To whom correspondence should be addressed at: University of California at San Francisco, Department of Neurology, Box 2922, 1550 4th Street, San Francisco, CA 94143-2922, USA. Email: ptacek{at}itsa.ucsf.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Therapeutic Advances in Neurological DisordersHome page
I. Unterberger and E. Trinka
Review: Diagnosis and treatment of paroxysmal dyskinesias revisited
Therapeutic Advances in Neurological Disorders, September 1, 2008; 1(2): 67 - 74.
[Abstract] [PDF]


Home page
NeurologyHome page
M. K. Bruno, H.-Y Lee, G.W.J. Auburger, A. Friedman, J. E. Nielsen, A. E. Lang, E. Bertini, P. Van Bogaert, Y. Averyanov, M. Hallett, et al.
Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia
Neurology, May 22, 2007; 68(21): 1782 - 1789.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
U. Muller, D. K. Simon, and D. Tarsy
Dystonia
N. Engl. J. Med., November 2, 2006; 355(18): 1935 - 1935.
[Full Text] [PDF]


Home page
NeurologyHome page
S. D. Spacey, P. J. Adams, P.C.P. Lam, L. A. Materek, A. J. Stoessl, T. P. Snutch, and G. -Y.R. Hsiung
Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia
Neurology, May 23, 2006; 66(10): 1588 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Djarmati, M. Svetel, D. Momcilovic, V. Kostic, and C. Klein
Significance of Recurrent Mutations in the Myofibrillogenesis Regulator 1 Gene
Arch Neurol, October 1, 2005; 62(10): 1641 - 1641.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.